Literature DB >> 8751876

The genetic basis of Muir-Torre syndrome includes the hMLH1 locus.

B Bapat, L Xia, L Madlensky, A Mitri, P Tonin, S A Narod, S Gallinger.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1996        PMID： 8751876      PMCID： PMC1914892     

Source DB:  PubMed          Journal:  Am J Hum Genet        ISSN： 0002-9297            Impact factor:   11.025


× No keyword cloud information.
  24 in total

1.  Mutation in the DNA mismatch repair gene homologue hMLH1 is associated with hereditary non-polyposis colon cancer.

Authors:  C E Bronner; S M Baker; P T Morrison; G Warren; L G Smith; M K Lescoe; M Kane; C Earabino; J Lipford; A Lindblom
Journal:  Nature       Date:  1994-03-17       Impact factor: 49.962

2.  Mutation of a mutL homolog in hereditary colon cancer.

Authors:  N Papadopoulos; N C Nicolaides; Y F Wei; S M Ruben; K C Carter; C A Rosen; W A Haseltine; R D Fleischmann; C M Fraser; M D Adams
Journal:  Science       Date:  1994-03-18       Impact factor: 47.728

3.  Multiple primary carcinomata of the colon, duodenum, and larynx associated with kerato-acanthomata of the face.

Authors:  E G Muir; A J Bell; K A Barlow
Journal:  Br J Surg       Date:  1967-03       Impact factor: 6.939

Review 4.  Association of sebaceous gland tumors and internal malignancy: the Muir-Torre syndrome.

Authors:  P R Cohen; S R Kohn; R Kurzrock
Journal:  Am J Med       Date:  1991-05       Impact factor: 4.965

5.  Muir-Torre syndrome in several members of a family with a variant of the Cancer Family Syndrome.

Authors:  H T Lynch; R M Fusaro; L Roberts; G J Voorhees; J F Lynch
Journal:  Br J Dermatol       Date:  1985-09       Impact factor: 9.302

6.  The human mutator gene homolog MSH2 and its association with hereditary nonpolyposis colon cancer.

Authors:  R Fishel; M K Lescoe; M R Rao; N G Copeland; N A Jenkins; J Garber; M Kane; R Kolodner
Journal:  Cell       Date:  1993-12-03       Impact factor: 41.582

7.  Analysis of mismatch repair genes in hereditary non-polyposis colorectal cancer patients.

Authors:  B Liu; R Parsons; N Papadopoulos; N C Nicolaides; H T Lynch; P Watson; J R Jass; M Dunlop; A Wyllie; P Peltomäki; A de la Chapelle; S R Hamilton; B Vogelstein; K W Kinzler
Journal:  Nat Med       Date:  1996-02       Impact factor: 53.440

8.  Mutations of a mutS homolog in hereditary nonpolyposis colorectal cancer.

Authors:  F S Leach; N C Nicolaides; N Papadopoulos; B Liu; J Jen; R Parsons; P Peltomäki; P Sistonen; L A Aaltonen; M Nyström-Lahti
Journal:  Cell       Date:  1993-12-17       Impact factor: 41.582

9.  Replication errors in benign and malignant tumors from hereditary nonpolyposis colorectal cancer patients.

Authors:  L A Aaltonen; P Peltomäki; J P Mecklin; H Järvinen; J R Jass; J S Green; H T Lynch; P Watson; G Tallqvist; M Juhola
Journal:  Cancer Res       Date:  1994-04-01       Impact factor: 12.701

10.  Microsatellite instability in Muir-Torre syndrome.

Authors:  R Honchel; K C Halling; D J Schaid; M Pittelkow; S N Thibodeau
Journal:  Cancer Res       Date:  1994-03-01       Impact factor: 12.701
View more
  13 in total

1.  An individual with Muir-Torre syndrome found to have a pathogenic MSH6 gene mutation.

Authors:  Angela Arnold; Stewart Payne; Samantha Fisher; Diane Fricker; Judith Soloway; Susan M White; Marco Novelli; Kylie MacDonald; James Mackay; Richard Groves; Natalie Canham
Journal:  Fam Cancer       Date:  2007-02-24       Impact factor: 2.375

2.  Muir-Torre Syndrome: expanding the genotype and phenotype--a further family with a MSH6 mutation.

Authors:  H R Murphy; R Armstrong; D Cairns; K L Greenhalgh
Journal:  Fam Cancer       Date:  2008-01-31       Impact factor: 2.375

3.  [Recurrent eyelid tumors with different dignities].

Authors:  U Löw; C S L Müller; E Zemova; F A Flockerzi; B Seitz
Journal:  Ophthalmologe       Date:  2019-11       Impact factor: 1.059

Review 4.  Genetic susceptibility to non-polyposis colorectal cancer.

Authors:  H T Lynch; A de la Chapelle
Journal:  J Med Genet       Date:  1999-11       Impact factor: 6.318

Review 5.  Genetics of skin appendage neoplasms and related syndromes.

Authors:  D A Lee; M E Grossman; P Schneiderman; J T Celebi
Journal:  J Med Genet       Date:  2005-11       Impact factor: 6.318

6.  [Muir-Torre syndrome with previously undescribed frameshift mutation in the MSH2 gene].

Authors:  B Gilly; A Unholzer; G Strobl-Wildemann; C Haas; H Starz; J Welzel
Journal:  Hautarzt       Date:  2013-04       Impact factor: 0.751

Review 7.  Parotid Sebaceous Carcinoma in Patient with Muir Torre Syndrome, Caused by MSH2 Mutation.

Authors:  Iyer Vishwas Neelakantan; Silvana Di Palma; C E T Smith; A McCoombe
Journal:  Head Neck Pathol       Date:  2015-11-17

8.  Synchronous gastric and sebaceous cancers, a rare manifestation of MLH1-related Muir-Torre syndrome.

Authors:  Jiří Svec; Lucie Schwarzová; Bohumila Janošíková; Jitka Stekrová; Václav Mandys; Milan Kment; Pavel Vodička
Journal:  Int J Clin Exp Pathol       Date:  2014-07-15

9.  Muir-Torre phenotype has a frequency of DNA mismatch-repair-gene mutations similar to that in hereditary nonpolyposis colorectal cancer families defined by the Amsterdam criteria.

Authors:  R Kruse; A Rütten; C Lamberti; H R Hosseiny-Malayeri; Y Wang; C Ruelfs; M Jungck; M Mathiak; T Ruzicka; W Hartschuh; M Bisceglia; W Friedl; P Propping
Journal:  Am J Hum Genet       Date:  1998-07       Impact factor: 11.025

10.  Identifying Muir-Torre syndrome in a patient with glioblastoma multiforme.

Authors:  Deric M Park; Gabrielle A Yeaney; Ronald L Hamilton; Jennifer Mabold; Nikki Urban; Leonard Appleman; John Flickinger; Frank Lieberman; Arlan Mintz
Journal:  Neuro Oncol       Date:  2008-11-21       Impact factor: 12.300
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.